Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/02/2011CN102228444A N(2)-L-alanyl-L-glutamine preparation for injection and preparation method thereof
11/02/2011CN102228443A Clevidipine butyrate microspheres and preparation method thereof
11/02/2011CN102228442A Star-like macromolecule nanometer microsphere and preparation method and application thereof
11/02/2011CN102228441A Dexibuprofen sustained-release pellet and preparation method thereof
11/02/2011CN102228440A Method for preparing hydrophilic drug microsphere through spray drying process
11/02/2011CN102228439A Gel microsphere capable of being injected with rifamycinoid antibiotics and preparation method thereof
11/02/2011CN102228438A Decoquinate gel microsphere and its preparation method
11/02/2011CN102228437A Co-immobilized TNF-a/IFN-g/DOX/FA/Fe3O4-OA magnetic targeted nanoparticle as well as preparation method and application thereof
11/02/2011CN102228436A Slow-release liquid crystal nanoparticle containing vinpocetine prepared by supercritical fluid method
11/02/2011CN102228435A Water-soluble vitamin liposome pharmaceutical composition formula and preparation method and application thereof
11/02/2011CN102228434A Clevidipine butyrate emulsion, preparation method thereof and purpose thereof
11/02/2011CN102228433A Supersaturated self-microemulsion as well as preparation method and application thereof
11/02/2011CN102228432A Ofloxacin nanoemulsion antibacterial medicine and preparation method thereof
11/02/2011CN102228431A Self-emulsified medicinal composition for taxane compounds
11/02/2011CN102228430A Nano-suspension for silybin-phospholipid complex and preparation method thereof
11/02/2011CN102228429A Lomefloxacin aspartate medicine composition for injection
11/02/2011CN102228428A Large volume injection composition containing vinpocetine and preparation method thereof
11/02/2011CN102228427A Vitexin glucoside injection and preparation method thereof
11/02/2011CN102228426A 21(R) argatroban intravenous injection with alcohol as solubilizer
11/02/2011CN102228425A Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof
11/02/2011CN102228424A Drug sustained-release system for treating tumours and preparation method thereof
11/02/2011CN102228423A Tolvaptan oral solid medicinal composition and preparation method thereof
11/02/2011CN102048692B Aerosol containing Breviscapine and preparation method thereof
11/02/2011CN102000231B Medicine composition for treating osteopathic diseases
11/02/2011CN101972394B Traditional Chinese medical external-use powder for treating children pulmonitis and preparation method thereof
11/02/2011CN101961431B Ointment for treating bone fractures
11/02/2011CN101940598B Preparation method of Huang children paracetamol-particles
11/02/2011CN101912470B Chinese medicinal powder for treating diabetes
11/02/2011CN101837083B Ointment for curing burns and scalds and preparation method thereof
11/02/2011CN101780212B Preparation method of sugar-free traditional Chinese medicine oral liquid for treating angina pectoris
11/02/2011CN101732492B Adinandra nitida leaf flavone oral tablet and preparation method
11/02/2011CN101732244B Nose drops taking fibrauretine as main medicine and preparation method
11/02/2011CN101716224B Externally applied powder for treating burns, scalds and wounds
11/02/2011CN101695489B Aztreonam composition, powder injection and preparation method thereof
11/02/2011CN101647844B Vinegar milk essence micro effervescent granules and preparation method thereof
11/02/2011CN101607086B Compound bismuth composition and preparation method thereof
11/02/2011CN101574397B WuRenChun self-emulsifying soft capsule preparation and preparation method
11/02/2011CN101559170B Epidemics clearing and sore-throat relieving tea
11/02/2011CN101549017B Traditional Chinese medicine composition for treating arrhythmia and preparation method thereof
11/02/2011CN101530598B Plaster used for hyperosteogeny
11/02/2011CN101461911B Chinese medicine oral capsule for treating gout
11/02/2011CN101297890B Chinese medicine powder for treating salpingitis of layer chicken and preparation thereof
11/02/2011CN101293032B Externally used Mongolian medicine powder preparation for treating leukoplakia vulvae and preparing method thereof
11/02/2011CN101269010B Ofloxacin injection and preparation method thereof
11/02/2011CN101249119B Compound compound paracetamol and zincgluconate dispersible tablet and method of preparing the same
11/02/2011CN101190263B Rhubarb chewable tablets and preparation method and application thereof
11/02/2011CN101190250B Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof
11/02/2011CN101190208B Medicinal preparations containing duloxetine hydrochloride and preparation method thereof
11/02/2011CN101168044B Product formula for lady daily nursing gel
11/02/2011CN101167843B 'Preparation method of yinzhihuang' injection
11/02/2011CN101125160B Method for preparing preparation for treating gastroenteritis and its new use
11/02/2011CN101108219B Method of preparing traditional Chinese medicine formulated product for treating gastroenteritis
11/02/2011CN101106911B Spray-dried compositions and their uses
11/02/2011CN101073537B Fine emulsion of oil in water
11/02/2011CN101058573B 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
11/02/2011CN101040951B Method of controlling the quality of Ynxingchao dropping pills compound
11/02/2011CN101003470B Analog of mono carbonyl structure of curcumin, and usage
11/01/2011US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011US8048989 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers
11/01/2011US8048919 Use of ethyl lactate as an excipient for pharmaceutical compositions
11/01/2011US8048876 Process for preparing quetiapine and quetiapine fumarate
11/01/2011US8048869 Estrogenic component comprising estetrol and estetrol-like substances, which has relatively low estrogenic potency, metabolic stability, long half-life; triene steroids; osteoporosis, arteriosclerosis, cognitive disturbances, Alzheimer's disease, peri- or post-menopausal disorders
11/01/2011US8048865 Method and pharmaceutical to treat spinal discs
11/01/2011US8048861 Pesticidal formulations
11/01/2011US8048844 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2011US8048453 Pharmaceutical composition of nanoparticles for protein drug delivery
11/01/2011US8048452 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
11/01/2011US8048451 Microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the
11/01/2011US8048450 Aqueous dispersion of hydrogel nanoparticles with inverse thermoreversible gelation
11/01/2011US8048449 Mouth dissolving pharmaceutical composition and process for preparing the same
11/01/2011US8048448 Nanoshells for drug delivery
11/01/2011US8048446 Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
11/01/2011US8048445 Bioerodible poly lactic co glycolic acid copolymer eye implant with active agents blended in; Risperidone; glaucoma
11/01/2011US8048444 Applying to the implant a bioresorbable membrane made of lactide polymers or lactone copolymers
11/01/2011US8048439 Therapeutic foam
11/01/2011US8048438 Apparatus for uniform delivery of drugs to biological systems
11/01/2011US8048407 In situ gelling self-reactive materials for embolization
11/01/2011US8048404 Pharmaceutical composition of nanoparticles for protein drug delivery
11/01/2011US8048101 Methods and devices for conduit occlusion
11/01/2011US8048086 Methods and devices for conduit occlusion
11/01/2011US8048015 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
11/01/2011CA2697570C Reduced volume formulation of glatiramer acetate and methods of administration
11/01/2011CA2661759C Buprenophine-wafer for drug substitution therapy
11/01/2011CA2629894C Pharmaceutical device for the administration of substances to patients
11/01/2011CA2617370C Improved cellular uptake of bioactive agents
11/01/2011CA2600023C Solvent system for enhancing the solubility of pharmaceutical agents
11/01/2011CA2596283C Embolization using poly-4-hydroxybutyrate particles
11/01/2011CA2564719C Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylactic acid derivative
11/01/2011CA2522962C Medical active substance patch with reduced optical conspicuousness on the skin
11/01/2011CA2522028C Methods and compositions for administration of trpv1 agonists
11/01/2011CA2518174C A non-smokable electronic spray cigarette
11/01/2011CA2517172C Therapeutic compositions
11/01/2011CA2507766C Novel dry powder inhalation system for transpulmonary administration
11/01/2011CA2493208C Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/01/2011CA2492976C Solution for ungual and peri-ungual application
11/01/2011CA2490351C Process for producing sustained-release composition
11/01/2011CA2490254C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/01/2011CA2475224C Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/01/2011CA2468254C Therapeutic coating for an intravascular implant
11/01/2011CA2453892C Alkyd-lactone copolymers for medical applications